ASG Webinar Series
We’re pleased to share our 2025 Webinar Series as part of our commitment to advance the scientific, educational, professional, and economic well-being of our members.
As we move into the end of the year, all sessions have now been recorded and are available in video format for on-demand viewing, supporting our ongoing commitment to education, collaboration, and professional development within the Alberta GI community.
By engaging with the webinar series, participants will be able to:
• Compare and contrast therapeutic approaches in the care of patients with a wide variety of gastrointestinal diseases
• Articulate the key findings of current research into objective monitoring for patients with IBD, liver, and luminal GI disorders
• Distill the latest and most salient information from recent publications and presentations
• Foster a provincial community of practice
Best of the Liver Meeting
Presenter:
Dr. Juan G. Abraldes
Professor of Medicine, Division of Gastroenterology, and Director of the Liver Unit, University of Alberta
Moderator:
Dr. Saumya Jayakumar
Associate Professor, Department of Medicine, Divison of Gastroenterology, University of Alberta
By the end of this session participants will be able to:
- Review key evidence-based findings from the Canadian Liver Meeting relevant to clinical practice
- Examine updates in the diagnosis and management of common liver conditions, including hepatitis, fatty liver disease, and cirrhosis
- Discuss practical considerations for applying recent research findings to patient care.
To view the webinar, log in to your account
Barrett's Esophagus
Presenter:
Dr. Clarence Wong
Professor and Director, Division of Gastroenterology, University of Alberta
Moderator:
Dr. Milli Gupta
Associate Clinical Professor of Medicine, Division of Gastroenterology and Hepatology, University of Calgary
By the end of this session participants will be able to:
• List the pathophysiology and risk factors associated with the development of Barrett's esophagus.
• Recognize the common symptoms and diagnostic criteria used to identify Barrett's esophagus in patients.
• Analyze available therapeutic interventions for managing Barrett's esophagus.
To view the webinar, log in to your account
Celiac Disease: Beyond the Gluten-Free Diet
Presenter:
Dr. Benjamin Lebwohl
Professor of Medicine and Epidemiology, Columbia University Medical Center, Director of Clinical Research, The Celiac Disease Center at Columbia University.
Moderator:
Dr. Gill Kaplan
Professor of Medicine & Community Health Sciences, University of Calgary Scientific Director, Digestive Health Strategic Clinical Network
By the end of this session participants will be able to:
- Describe global trends in the epidemiology and diagnosis of celiac disease, including rising incidence rates and patterns of underdiagnosis across diverse populations.
- Distinguished celiac disease from other conditions with overlapping clinical or historical features, such as isolated gliadin-peptide elevation and non non-celiac villus atrophy
- Evaluate emerging non-dietary therapeutic strategies and clinical trial designs for celiac disease, with a focus on endpoint selection and regulatory consideration.
To view the webinar, log into your account
What is the Future of IBD Therapeutics?
Presenter:
Dr. Christopher Ma
Associate Professor, University of Calgary
Moderator
Dr. Frank Hoentjen
Professor, Faculty of Medicine & Dentistry, Department of Medicine, University of Alberta
By the end of this session participants will be able to:
- Discuss the current state of advanced therapies for IBD and what we can expect in the next 10 years
- Identify emerging therapeutic targets and novel mechanisms of action in the treatment of IBD
- Evaluate how future developments in precision medicine and biomarkers may influence personalized treatment strategies for IBD patients;
Following the webinar, please stay for a symposium sponsored by Johnson & Johnson, where Dr. Ma will continue his discussion on IBD Therapeutics.
To view the webinar, log into your account
This webinar has received an educational grant or in-kind support from:
Pfizer, AbbVie, Celltrion, Johnson & Johnson, Takeda, Lilly, Ipsen, Gilead, Amgen, Organon, Merck, Pentax, GSK, Ferring Pharmaceuticals, Fresenius-Kabi, Sanofi, Boston Scientific, Avir Pharma, Cencora Innomar Strategies. Sandoz, Pendopharm, Lupin